Chapters

Transcript

Video

Toni Choueiri, MD Shares the Latest Data From COSMIC-313

Kidney Cancer triplet slows progression in advanced disease when compared to immunotherapy combo (nivolumab + ipilimumab). 


Published

September 21, 2022

Created by

Dana-Farber

Related Presenters

Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology

Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair ...

View Full Profile